PDS Biotech Reports Second Quarter 2022 Financial Results and Provides Business Update

08.08.2022 - Announced results from two of the ongoing Phase 2 clinical trials of PDS0101 in multiple, difficult-to-treat HPV16-related cancers presented at the American Society of Clinical Oncology meetingPromising pre-clinical data on universal flu vaccine ...

Related Keywords

United States ,United Kingdom ,Russia ,Ukraine ,American ,Frank Bedu ,Deanne Randolph ,American Society Of Clinical Oncology ,Twitter ,Company Infectimune ,Drug Administration ,Biotechnology Corporation The Company ,Merck Co Inc ,United States Securities Exchange ,National Cancer ,Business Development ,American Society Of Virology ,Granted Fast Track Designation ,American Society ,Clinical Oncology ,National Cancer Institute Led ,Spencer Brown ,Senior Vice President ,General Counsel ,Sanjay Zaveri ,Frank Bedu Addo ,Chief Executive Officer ,Merck Sharp ,United States Securities Exchange Act ,States Securities Act ,Consolidated Statements ,Months Ended June ,